Education

Studies show psilocybin therapy has potential for anorexia nervosa and severe treatment-resistant depression

Positive Early Signals Seen in Two Investigator-Initiated Studies Presented at the Society of Biological Psychiatry Annual Meeting in New Orleans COMPASS Pathways (COMPASS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced that positive data two investigator-initiated studies demonstrating the potential of COMP360 psilocybin therapy in anorexia …

Studies show psilocybin therapy has potential for anorexia nervosa and severe treatment-resistant depression Read More »

Psychedelic Research Company Developing Sustainably-Grown Peyote in Canada

Lophos Pharmaceuticals Corp. is a Canadian psychedelic research company focused on peyote and its derivatives such as mescaline. Peyote, an endangered plant species with a long history of therapeutic use, has legal status in Canada, but mescaline, a powerful psychedelic molecule derived from the plant, remains a Schedule 3 controlled substance. At their facility, Lophos Pharma …

Psychedelic Research Company Developing Sustainably-Grown Peyote in Canada Read More »

Study Released to Protect the Development of LSD-based Therapies from Unfounded Patent Claims

New Study Establishes the Existence of a Single Polymorphic Form of LSD D Tartrate The non-profit Freedom to Operate (FTO), has just published new research on the polymorphic form of Lysergic acid diethylamide (LSD) D-tartrate, a common salt form of LSD. In furtherance of its mission to advance science and education, specifically research, in the public interest and for …

Study Released to Protect the Development of LSD-based Therapies from Unfounded Patent Claims Read More »

New Study Explores Relationship Between Psychedelics and Consciousness

Psychedelic drugs, like psilocybin, an ingredient found in so-called magic mushrooms, have shown promise in treating a range of addictions and mental health disorders. Yet, there’s something mysterious and almost mystical about their effects, and they are commonly believed to provide unique insights into the nature of consciousness. Now, a new study by Johns Hopkins …

New Study Explores Relationship Between Psychedelics and Consciousness Read More »

LSD: A Future Anti-Anxiety Pill?

New Study by Dr. Gabriella Gobbi Reveals the Neurobiological Mechanisms by which LSD could Relieve Anxiety The craze for psychedelics used for therapeutic purposes is real. However, the scientific evidence supporting their effectiveness and explaining their mode of action in treating mental health disorders is still very thin. A new study led by Dr. Gabriella …

LSD: A Future Anti-Anxiety Pill? Read More »

The Potential Role of Psychedelics in Cancer Treatment

Psilocybin shown to aid in cancer-related mental health conditions Cancer is a modern chronic disease characterized by abnormal cells dividing uncontrollably. There are over 200 types of cancer, some of which may spread into other body tissues.  Cancer is the leading cause of death in Canada, responsible for over 28 percent of all deaths. Researchers …

The Potential Role of Psychedelics in Cancer Treatment Read More »

Study Shows Psilocybin Treatment for Major Depression Effective for Up to a Year for Most Patients

Previous studies by Johns Hopkins Medicine researchers showed that psychedelic treatment with psilocybin relieved major depressive disorder symptoms in adults for up to a month. Now, in a follow-up study of those participants, the researchers report that the substantial antidepressant effects of psilocybin-assisted therapy, given with supportive psychotherapy, may last at least a year for some patients. …

Study Shows Psilocybin Treatment for Major Depression Effective for Up to a Year for Most Patients Read More »

Monash University-Led Team Receives Funding for Psychedelic Psychotherapy in Treatment-Resistant Depression

The Medical Research Future Fund Clinical Trials Activity Initiative has awarded $2.7M for Innovative Therapies for Mental Illness to a Monash University-led team, to evaluate the efficacy of psilocybin-assisted psychotherapy in treatment-resistant depression. Major Depressive Disorder (MDD) is, sadly, common, and results in the greatest global burden of disease. Although there are established treatments for …

Monash University-Led Team Receives Funding for Psychedelic Psychotherapy in Treatment-Resistant Depression Read More »

Using Psychedelics for Terminal Illness and End of Life

Death is the one thing all humans have in common, and everyone deserves to end their lives with dignity. There are several physical, mental, and emotional symptoms those at the end of life can face depending on their condition: pain, dyspnea (shortness of breath), mental confusion or delirium, agitation (also known as terminal restlessness), and …

Using Psychedelics for Terminal Illness and End of Life Read More »

Scroll to Top